More Business Wire
View Older Stories View Newer Stories-
TME Pharma Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two‑Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer
-
Antech’s breakthrough cancer screening tool launches in Europe, supporting early canine cancer detection
-
Legrand pursues its investments in buoyant segments
-
foodpanda and The Trade Desk Partner Up to Provide Brands With Data-Driven Retail Media Solutions
-
TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024
-
BenevolentAI Provides an Update on Its Business Priorities
-
KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma
-
U.S. Approval Steady Before Election Year, But Election Results Could Reshape U.S. Foreign Policy and the Global Order
-
Gallup Report Finds Germany Remains Top-Rated Global Power for Seventh Year, Gains Additional Ground in Europe and Asia
-
Kioxia Sampling Latest Generation UFS Ver. 4.0 Embedded Flash Memory Devices
-
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
-
Wolfspeed Comments on Letter from JANA Partners
-
Quectel showcases IoT offering at Japan IT Week Spring in Tokyo
-
Silver Storm Announces 2024 Brand Awareness Program and Grant of Incentive Stock Options
-
Lucidea, Developer of ArchivEra CMS, to Sponsor MAC 2024
-
XTM Announces Delay in Its Annual Filings
-
KBRA Assigns Preliminary Ratings to Pagaya AI Debt Grantor Trust 2024-S1 and Pagaya AI Debt Trust 2024-S1
-
Extension of Deadline in Accordance with Rule 2.6(c) of the Irish Takeover Rules
-
PNFP Reports 1Q24 Diluted EPS of $1.57
-
EverGen Infrastructure Reports Q4 & Year End 2023 Results
-
JBG SMITH Releases 2024 Sustainability Report
-
Primerica Schedules First Quarter 2024 Financial Results Webcast
-
UnitedHealth Group Updates on Change Healthcare Cyberattack
-
Overseas Shipholding Group Awarded Federal Grant to Design Marine Transport For Liquified CO2 Captured by Florida’s Largest Emitters
-
Coke Florida Celebrates Earth Day with Statewide Sustainability and Conservation Activities
-
ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
Panish | Shea | Ravipudi LLP Attorney Tom Schultz Named Partner
-
GigNet and IotaComm to Collaborate on Internet-of-Things (IoT) Solutions for the Mexican Caribbean
-
Swisslog Healthcare Welcomes Brian Roberts as SVP of Medication Management, North America
-
Claros Mortgage Trust, Inc. Announces Dates for First Quarter 2024 Earnings Release and Conference Call
-
Capri Holdings Limited Issues Statement on FTC Action Seeking to Block Proposed Transaction with Tapestry, Inc.
-
iSun, Inc. Announces Restructuring of Executive Team
-
Resilient Waters Fund Wins the 2024 Kellogg-Morgan Stanley Sustainable Investing Challenge
-
Independent Bank Group, Inc. Reports First Quarter Financial Results and Declares Quarterly Dividend
-
WaFd Reports Second Quarter Fiscal 2024 Results Following Completion of Merger of Luther Burbank Corporation
-
Bowlero to Report Third Quarter 2024 Financial Results on May 6, 2024
-
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
-
Metals Acquisition Limited Announces Updated Resource and Reserve Statement and Production Guidance
-
Atkore Inc. Announces Participation at Upcoming Investor Conferences
-
Vasta Platform Limited to Report First Quarter 2024 Financial Results on May 08, 2024
-
United Homes Group Announces Board of Directors Update
-
Archer To Report First Quarter 2024 Operating Update and Financial Results on May 9, 2024
-
Tapestry, Inc. Responds to the FTC’s Lawsuit
-
Equity Bancshares, Inc. Expands Footprint Within Home State of Kansas
-
Browning West and Glenn Chamandy Comment on Gildan Activewear’s Defensive and Reactionary Board Refreshment
-
Seagate Drives Progress on Its Renewable Energy and Circularity Programs
-
Alterra Mountain Company Releases Its 2023 Impact Report
-
ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
-
Innovative Industrial Properties to Report 2024 First Quarter Results
-
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting

